First Randomized, Placebo-Controlled Study of Hydroxychloroquine Shows Benefit In Time to Heal and Overall Recovery

First randomized, placebo-controlled RCT of hydroxychloroquine (without azithromycin) published in 62 Chinese patients suggests benefit in both time to overall recovery, & decreased likelihood of progressing to severe disease, absent major side effectshttps://t.co/ssRyfFdZkk pic.twitter.com/G8avfxl3A8

— Andrew Bostom (@andrewbostom) March 31, 2020